SLC22A7
solute carrier family 22 member 7
Pathway candidate — not linked to PFS or PSSD by any record here
Gene summary
A protein-coding gene on chromosome 6 (drug and xenobiotic transporters). The protein encoded by this gene is involved in the sodium-independent transport and excretion of organic anions, some of which are potentially toxic. The protein is an integral membrane protein and appears to be localized to the basolateral membrane of the kidney.
Source: NCBI Gene, accessed 2026-10-07.
Protein reference (UniProt)
- Protein
Solute carrier family 22 member 7
- Function (excerpt)
Isoform 2: Functions as a Na(+)-independent bidirectional multispecific transporter. Contributes to the renal and hepatic elimination of endogenous organic compounds from the systemic circulation into the urine and bile, respectively. Capable of transporting a wide range of purine and pyrimidine nucleobases, nucleosides and nucleotides, with cGMP, 2'deoxyguanosine and GMP being the preferred substrates. Functions as a pH- and chloride-independent cGMP bidirectional facilitative transporter that can regulate both intracellular and extracellular levels of cGMP and may be involved in cGMP signaling pathways. Mediates orotate/glutamate bidirectional exchange and most likely display a physiological role in hepatic release of glutamate into the blood. Involved in renal secretion and possible reabsorption of creatinine. Able to uptake prostaglandin E2 (PGE2) and may contribute to PGE2 renal excretion (Probable). Also transports alpha-ketoglutarate and urate.
- Subcellular location
Basolateral cell membrane; Apical cell membrane; Cell membrane; Cytoplasm, cytosol.
- Tissue specificity
Mainly expressed in liver and kidney. In kidney, expressed in proximal tubular cells. Also expressed in pancreas, small intestine, spinal cord, lung, brain and heart. Expressed in fetal liver.
Source: UniProtKB/Swiss-Prot Q9Y694, release 2026_03, licensed CC BY 4.0. This is the protein’s normal biology, not evidence about post-drug syndromes; associated conditions are inherited disorders of the gene, not PFS, PSSD or PRSD.
Why its pathway is in the library
Transporters set systemic exposure to finasteride/SSRIs and clear conjugated steroid metabolites — directly relevant to both drug pharmacokinetics and Powers' clearance-centered PFS mechanism.
Written for the whole drug transporters family, not for SLC22A7 specifically.
Mentioned in 0 corpus records
No corpus record names SLC22A7 directly yet. It is in the library because it sits in a pathway the corpus tracks (Drug transporters).
Also in drug and xenobiotic transporters
All 62 genes- SLC6A4
solute carrier family 6 member 4
chr 17· Drug transporters· 10 records - ABCC2Powers
ATP binding cassette subfamily C member 2
chr 10· Drug transporters· 6 records - ABCC3Powers
ATP binding cassette subfamily C member 3
chr 17· Drug transporters· 5 records - ABCB1
ATP binding cassette subfamily B member 1
chr 7· Drug transporters· 3 records - ABCC5Powers
ATP binding cassette subfamily C member 5
chr 3· Drug transporters· 3 records - SLCO1B1Powers
solute carrier organic anion transporter family member 1B1
chr 12· Drug transporters· 4 records - SLC18A2
solute carrier family 18 member A2
chr 10· Drug transporters· 1 record - SLCO1B3
solute carrier organic anion transporter family member 1B3
chr 12· Drug transporters· 1 record
Browse by family on the gene families page.
